Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro is not available on Clearpay in the UK. Because tirzepatide is a Prescription-Only Medicine, every legitimate sale requires a clinical assessment by a registered prescriber before a prescription can be issued — and the payment infrastructure most regulated pharmacies use does not accommodate buy-now-pay-later services for POMs. That is the short answer. The longer one is worth reading, because the question of how to afford Mounjaro safely is one a lot of people are genuinely wrestling with, and the answer has more nuance than a flat no.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The restriction here is not arbitrary. Under the Human Medicines Regulations 2012, Prescription-Only Medicines can only be supplied following a valid prescription issued by an authorised prescriber. UK-regulated pharmacies, those you can verify on the GPhC register, structure their payment flows around that clinical step, the prescription is generated, checked and dispensed as a single regulated transaction. Integrating a deferred-payment scheme into that process raises compliance questions that most GPhC-registered pharmacies have chosen not to navigate.
That means the absence of Clearpay is not a gap you will find plugged by a more convenient provider. It is a consistent feature of how legitimate prescription treatment is sold in the UK. A question our prescribers hear most weeks is whether there is any instalment route for Mounjaro, and the honest answer, consistently, is that there isn't one through a regulated pharmacy.
It is worth knowing what Mounjaro actually costs in the private market, because context helps. Eli Lilly raised the UK list price from 1 September 2025; since then, typical private prices by dose and provider have ranged roughly from £149 to £375 per month, as widely reported following Lilly's announcement. You can find a more detailed breakdown on our Mounjaro pricing page. That range explains why pay-later options feel appealing, and why it matters to understand the risks when cheaper-seeming routes appear.
Search for Mounjaro on Clearpay and you will find a mix of things: some legitimate pharmacies explaining why they don't offer it, some comparison sites that simply list payment methods without full context, and some sellers whose listings should give you pause. The MHRA has issued multiple public warnings about counterfeit and illegally traded weight-loss pens, in October 2025, enforcement teams raided the first illicit UK site manufacturing fake tirzepatide pens, and across 2025 approximately 20 million doses of illegally traded weight-loss medicines (around £45 million in street value) were seized. The common thread in many of those cases is price: pens offered well below market rate, often through social-media channels, often with flexible payment methods that legitimate pharmacies don't use.
Red flags to recognise: a seller offering these medicines without a clinical assessment, prices far below the £149–£375/month private range, payment via buy-now-pay-later or cryptocurrency, no GPhC registration visible. If you come across a suspicious seller, you can report them through the MHRA's Yellow Card scheme. That is not a bureaucratic nicety, fake pens have been found to contain insulin rather than tirzepatide, which has caused serious harm. Details on spotting safe sellers are covered on our guide to where to buy Mounjaro responsibly.
The broader picture on Mounjaro via Clearpay or Klarna is the same: neither service is used by regulated UK pharmacies for POMs, and any listing suggesting otherwise merits scrutiny.
The cost is real and the frustration is understandable. A few things are worth knowing. First, some people qualify for Mounjaro through the NHS, NICE recommended tirzepatide (TA1026) for adults with a BMI of 35 or above plus at least one weight-related condition, with lower BMI thresholds for some ethnic backgrounds, and NHS England is rolling out access in phases through 2026 and 2027. If you meet the criteria, that route is free. Second, private treatment costs vary by dose, treatment starts at 2.5mg (a settling-in dose) and titrates upward, so early months are typically at a lower price point. Third, a single transparent price that includes consultation, prescription, clinical review and delivery often works out differently from a headline pen price that excludes some of those things.
nume's position is that we are not competing on price, one all-in price covers your consultation, prescription, treatment, and free next-working-day delivery, with clinical aftercare available seven days a week. There are no subscriptions or auto-renewals; every repeat is clinically reviewed. You can read more about how we work on our about us page, or explore the treatment options we offer to see which might suit your situation.
If you are considering whether tirzepatide is right for you and want to understand the full picture, our Mounjaro overview covers the clinical evidence, eligibility, and what the treatment involves day to day. The Mounjaro cost page goes further into what different private providers do and don't include in their headline prices, because what looks like a saving on paper is not always one in practice. And if you have already looked at reviews from patients who have tried to pay via instalment services, this roundup puts those accounts in useful context.
It bears saying plainly: the reason Mounjaro requires a prescription is not a formality. Tirzepatide is a powerful medicine with a real side-effect profile, mostly gastrointestinal effects that are manageable with the right support, but also more serious signals that require a prescriber who knows your medical history. The NHS tirzepatide information page covers common and serious side effects clearly. A prescriber also needs to know about other medicines you take, conditions you have, and whether you are pregnant, trying to conceive, or breastfeeding, none of which a payment-processing workaround can assess.
At nume, every consultation is read by a GPhC-registered Independent Prescriber on the day it arrives. A real clinician reviews it, not automated scoring, not a queued triage algorithm. That is the part a Clearpay arrangement cannot replicate, and it is the part that actually keeps you safe. If you would like to find out whether you are clinically suitable, the next step is straightforward.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.